当前位置:首页 - 行情中心 - 亚宝药业(600351) - 财务分析

亚宝药业

(600351)

  

流通市值:43.42亿  总市值:43.42亿
流通股本:7.20亿   总股本:7.20亿

亚宝药业(600351)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至第三季度实现净利润2.28亿元,每股收益0.32元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至第三季度最新股东权益298482.41万元,未分配利润128890.78万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至第三季度最新总资产369323.50万元,负债70841.09万元。

利润表
报告期2024-09-302024-06-302024-03-312023-12-31
营业总收入2,121,509,818.791,443,686,437.98771,213,413.142,909,765,256.74
营业总成本1,854,942,934.531,246,402,129.14644,615,339.062,620,740,517.25
营业利润288,373,771.98212,141,585.97136,938,247.92226,335,032.35
利润总额284,011,333.98212,806,112.58137,387,366.27218,981,222.65
净利润228,467,854.51175,191,777.35109,772,004.55179,913,685.23
其他综合收益----4,402,698.14
综合收益总额228,467,854.51175,191,777.35109,772,004.55175,510,987.09
资产负债表
报告期2024-09-302024-06-302024-03-312023-12-31
流动资产合计1,657,708,555.211,709,637,384.531,730,881,154.361,753,042,705.21
非流动资产合计2,035,526,473.522,044,303,637.792,066,229,594.042,100,594,003.79
资产总计3,693,235,028.733,753,941,022.323,797,110,748.43,853,636,709
流动负债合计637,351,004.55792,686,232.96799,255,244.14785,463,994.12
非流动负债合计71,059,923.7472,434,242.3466,454,715.9474,866,819.63
负债合计708,410,928.29865,120,475.3865,709,960.08860,330,813.75
归属于母公司股东权益合计2,952,235,544.542,876,285,769.932,916,775,722.642,976,188,510.38
股东权益合计2,984,824,100.442,888,820,547.022,931,400,788.322,993,305,895.25
负债和股东权益合计3,693,235,028.733,753,941,022.323,797,110,748.43,853,636,709
现金流量表
报告期2024-09-302024-06-302024-03-312023-12-31
经营活动现金流入小计1,899,547,705.511,348,100,467.12776,858,863.982,899,964,738.78
经营活动现金流出小计1,517,127,355.831,005,959,916.85497,501,090.532,402,411,158.95
经营活动产生的现金流量净额382,420,349.68342,140,550.27279,357,773.45497,553,579.83
投资活动现金流入小计6,908,988.166,123,891.022,070,336.7176,009,744.39
投资活动现金流出小计45,704,795.3130,855,842.1611,072,346.15203,381,284.62
投资活动产生的现金流量净额-38,795,807.15-24,731,951.14-9,002,009.44-127,371,540.23
筹资活动现金流入小计133,742,947.9690,000,00090,000,000348,600,000
筹资活动现金流出小计491,823,805.79376,671,195.19266,075,273.97795,352,508.47
筹资活动产生的现金流量净额-358,080,857.83-286,671,195.19-176,075,273.97-446,752,508.47
汇率变动对现金及现金等价物的影响47,145.4949,690.2131,480.8412,834.96
现金及现金等价物净增加额-14,409,169.8130,787,094.1594,311,970.88-76,557,633.91
期末现金及现金等价物余额551,054,572.8596,250,836.76659,775,713.49565,463,742.61
TOP↑